Mode
Text Size
Log in / Sign up

nebivolol

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of nebivolol

32 trials tracked of nebivolol: 29 in phase 3 or 4 and 5 with published results. The most-cited published study has 23 citations.

32Trials tracked
29Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 25 Phase 3 4 Phase 2 1 Other / NA 2
  1. Phase 4 Nebivolol and the Endothelin (ET)-1 System Completed · 23 cited
  2. Phase 3 24 Hour Ambulatory Cardiac Oxygen Consumption Completed · 16 cited
  3. Phase 4 Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients Completed · 11 cited
  4. Phase 4 Nebivolol and Endothelial Regulation of Fibrinolysis (NERF) Completed · 9 cited
  5. Phase 4 Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients Completed · 7 cited
  6. Phase 4 Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease Completed
Show 26 more trials
  1. Phase 4 Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart Completed
  2. Phase 4 Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life Completed
  3. Phase 4 Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension Completed
  4. Phase 4 Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide Completed
  5. Phase 4 Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy Completed
  6. Phase 4 Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects. Completed
  7. Phase 4 The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease Completed
  8. Phase 4 A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy Completed
  9. Phase 4 Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients Completed
  10. Phase 4 Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients Completed
  11. Phase 4 Nebivolol, Lifestyle Modification and Arterial Stiffness Completed
  12. Phase 4 Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) Completed
  13. Phase 4 Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients Completed
  14. Phase 4 Nebivolol Versus Metoprolol: Sodium Sensitivity Completed
  15. Phase 4 A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients Completed
  16. Phase 4 Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells Completed
  17. Phase 4 Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome Completed
  18. Phase 4 Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques Completed
  19. Phase 4 Nebivolol in Patients With Systolic Stage 2 Hypertension Completed
  20. Phase 4 The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension Completed
  21. Phase 3 Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure Completed
  22. Phase 3 Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries Completed
  23. Phase 3 A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients Completed
  24. Phase 2 A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function Completed
  25. N/A The Effect of Nebivolol on Insulin Sensitivity Completed
  26. N/A Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function Completed

Showing the 32 most-cited and recently-updated of 32 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.